Evaluation of β-glucan particles as dual-function carriers for poorly soluble drugs
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60461373%3A22340%2F21%3A43922896" target="_blank" >RIV/60461373:22340/21:43922896 - isvavai.cz</a>
Result on the web
<a href="https://doi.org/10.1016/j.ejpb.2021.08.001" target="_blank" >https://doi.org/10.1016/j.ejpb.2021.08.001</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.ejpb.2021.08.001" target="_blank" >10.1016/j.ejpb.2021.08.001</a>
Alternative languages
Result language
angličtina
Original language name
Evaluation of β-glucan particles as dual-function carriers for poorly soluble drugs
Original language description
Yeast glucan particles are porous polysaccharide cell walls extracted from Saccharomyces cerevisiae. Being mildly immunogenic, they are efficiently phagocytosed and have therefore been proposed as possible vehicles for drug delivery. Using curcumin as a model poorly water-soluble drug, a systematic comparison of three different physical loading methods – incipient wetness impregnation, slurry evaporation, and spray drying – was carried out and their influence on the particle morphology, encapsulation efficiency, amorphous drug content and release kinetics was evaluated. It was found that yeast glucan particles can contain up to 30% wt. of curcumin in the amorphous form when prepared by slurry evaporation. The dissolution of curcumin from glucan particles lead to a supersaturated solution in a similar way as amorphous solid dispersions do, despite the fact that glucan particles themselves do not dissolve. Bi-phasic dissolution tests revealed up to 4-fold acceleration of curcumin dissolution rate from amorphous glucan particles compared to its crystalline form. Crucially, glucan particles were shown to retain the ability to be recognised and phagocytosed even after drug encapsulation. © 2021 Elsevier B.V.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
20401 - Chemical engineering (plants, products)
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
European Journal of Pharmaceutics and Biopharmaceutics
ISSN
0939-6411
e-ISSN
—
Volume of the periodical
168
Issue of the periodical within the volume
November 2021
Country of publishing house
US - UNITED STATES
Number of pages
11
Pages from-to
15-25
UT code for WoS article
000704283500002
EID of the result in the Scopus database
2-s2.0-85113534857